<unk>  is an antineoplastic agent that is FDA approved for the treatment of multiple sclerosis, pain related to advanced hormone-refractory prostate cancer, and acute nonlymphocytic leukemia (ANLL). There is a Black Box Warning for this drug as shown here.  Common adverse reactions include alopecia, diarrhea, inflammatory disease of mucous membrane, nausea, vomiting, decreased hemoglobin, decreased lymphocyte count, decreased white blood cell count, leukopenia, liver function tests abnormal, headache, urinary tract infectious disease, and disorder of menstruation.
Mitoxantrone
Ifosfamide
Dihydroergocristine
Mafosfamide
Floxuridine
Pirarubicin
Vidarabine
Mitomycin 